In conversation with....

Type 1 diabetes and immune-based therapies

October 26, 2018 The Lancet
In conversation with....
Type 1 diabetes and immune-based therapies
Show Notes

Mark Atkinson and Bart Roep join The Lancet Diabetes & Endocrinology to discuss a new Series on immune-based therapies for type 1 diabetes.